Hip Replacement in Osteoarthritis Patients Clinical Trial
Official title:
Evaluation of the Furlong Evolution Uncemented Hip Prosthesis With Special Emphasize on the Use of Collared Design or Not. A Prospective, Randomized Study Evaluated by RadioStereometric Analysis (RSA) and DXA.
| Verified date | December 2023 |
| Source | Region Skane |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The aim of this study is to further investigate the clinical and radiological importance of design changes in cementless hip prosthesis. The investigators have earlier evaluated the classical Furlong HAC total hip prosthesis and a first design change Furlong Active. Now a further development, Furlong Evolution, is to be evaluated. This prosthesis, furthermore, comes with and without a collar, and the investigators are going to randomize between the two. The investigators hypothesize that the new design will be easier to implant and will present equal or less migration than the older designs which would imply a favourable outcome in the long term. The investigators further hypothesize that the collar play no major part for the long term migration and bone remodelling. We will now do a 10 year follow up of the patients including RSA, DXA and PROMS
| Status | Active, not recruiting |
| Enrollment | 50 |
| Est. completion date | May 2024 |
| Est. primary completion date | July 2013 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 40 Years to 80 Years |
| Eligibility | Inclusion Criteria: - Primary osteoarthritis of the hip necessitating primary hip replacement - A femur considered suitable for uncemented fixation of the stem - Biological age <75 years old at the inclusion time of the study. Exclusion Criteria: - Rheumatoid arthritis - Malignant disease - Severe osteoporosis - Earlier fracture or operation in the hip to be operated on - Peroperative fracture - Ongoing corticosteroid (oral) or immunosuppressive medication - Personal disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain. |
| Country | Name | City | State |
|---|---|---|---|
| Sweden | Department of Orthopedics, Skane University Hospital, Lund University | Lund | Skåne |
| Lead Sponsor | Collaborator |
|---|---|
| Region Skane | JRI Orthopaedics Ltd |
Sweden,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Radiostereometric Analysis (RSA) | This will measure the change in migration (translation and rotation around the x-, y-, and z-axis of the hip) over time. The migration pattern the first 2 years can predict the long term outcome. | The first postoperative day, 14 days, 3 months, 1, 2, 5 and 10 years | |
| Secondary | Dual-energy X-ray absorptiometry (DXA) | This will measure the change in bone density around the prosthesis during the first important year. This will tell if there is a bone resorption around the stem or cup. | 14 days postoperatively and after 1, 5 and 10 years | |
| Secondary | General health questionnaire | EuroQol (EQ-5D) - a standardized instrument for use as measure of general health outcome over time | Preoperatively (3-4 weeks) and 1, 2, 5 and 10 years postoperatively | |
| Secondary | Hip specific health questionnaire | Hip disability and Osteoarthritis Outcome Score (HOOS) - this is a hip specific questionnaire that will measure how the operation has affected the patients function and pain situation. | Preoperatively (3-4 weeks) and 1, 2, 5 and 10 years postoperatively |